Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 208

2.

Effect of basic fibroblast growth factor on experimental focal ischemia studied by diffusion-weighted and perfusion imaging.

Tatlisumak T, Takano K, Carano RA, Fisher M.

Stroke. 1996 Dec;27(12):2292-7; discussion 2298.

3.

Delayed neuroprotective effect of insulin-like growth factor-i after experimental transient focal cerebral ischemia monitored with mri.

Schäbitz WR, Hoffmann TT, Heiland S, Kollmar R, Bardutzky J, Sommer C, Schwab S.

Stroke. 2001 May;32(5):1226-33.

4.

A novel endothelin antagonist, A-127722, attenuates ischemic lesion size in rats with temporary middle cerebral artery occlusion: a diffusion and perfusion MRI study.

Tatlisumak T, Carano RA, Takano K, Opgenorth TJ, Sotak CH, Fisher M.

Stroke. 1998 Apr;29(4):850-7; discussion 857-8.

7.

Combined perfusion and diffusion-weighted magnetic resonance imaging in a rat model of reversible middle cerebral artery occlusion.

Müller TB, Haraldseth O, Jones RA, Sebastiani G, Godtliebsen F, Lindboe CF, Unsgård G.

Stroke. 1995 Mar;26(3):451-7; discussion 457-8.

8.

Glycine site antagonist attenuates infarct size in experimental focal ischemia. Postmortem and diffusion mapping studies.

Takano K, Tatlisumak T, Formato JE, Carano RA, Bergmann AG, Pullan LM, Bare TM, Sotak CH, Fisher M.

Stroke. 1997 Jun;28(6):1255-62; discussion 1263.

9.

[Application of diffusion-weighted and perfusion magnetic resonance imaging in definition of the ischemic penumbra in hyperacute cerebral infarction].

Feng XY, Liang J, Yin XD, Han X, Dong Q, Lü CZ.

Zhonghua Yi Xue Za Zhi. 2003 Jun 10;83(11):952-7. Chinese.

PMID:
12899795
10.

In vivo neuroprotective effects of ACEA 1021 confirmed by magnetic resonance imaging in ischemic stroke.

Petty MA, Neumann-Haefelin C, Kalisch J, Sarhan S, Wettstein JG, Juretschke HP.

Eur J Pharmacol. 2003 Aug 1;474(1):53-62.

PMID:
12909195
11.

Serial MRI after transient focal cerebral ischemia in rats: dynamics of tissue injury, blood-brain barrier damage, and edema formation.

Neumann-Haefelin T, Kastrup A, de Crespigny A, Yenari MA, Ringer T, Sun GH, Moseley ME.

Stroke. 2000 Aug;31(8):1965-72; discussion 1972-3.

12.

Polynitroxyl albumin reduces infarct size in transient focal cerebral ischemia in the rat: potential mechanisms studied by magnetic resonance imaging.

Beaulieu C, Busch E, Röther J, de Crespigny A, Hsia CJ, Moseley ME.

J Cereb Blood Flow Metab. 1998 Sep;18(9):1022-31.

PMID:
9740106
13.

Effects of a novel NMDA antagonist on experimental stroke rapidly and quantitatively assessed by diffusion-weighted MRI.

Minematsu K, Fisher M, Li L, Davis MA, Knapp AG, Cotter RE, McBurney RN, Sotak CH.

Neurology. 1993 Feb;43(2):397-403.

PMID:
7679781
14.
15.

Reversible focal ischemic injury demonstrated by diffusion-weighted magnetic resonance imaging in rats.

Minematsu K, Li L, Sotak CH, Davis MA, Fisher M.

Stroke. 1992 Sep;23(9):1304-10; discussion 1310-1.

16.
17.
18.

Effects of ifenprodil, a polyamine site NMDA receptor antagonist, on reperfusion injury after transient focal cerebral ischemia.

Doğan A, Rao AM, Başkaya MK, Rao VL, Rastl J, Donaldson D, Dempsey RJ.

J Neurosurg. 1997 Dec;87(6):921-6.

PMID:
9384405
19.

Transient and permanent resolution of ischemic lesions on diffusion-weighted imaging after brief periods of focal ischemia in rats : correlation with histopathology.

Li F, Liu KF, Silva MD, Omae T, Sotak CH, Fenstermacher JD, Fisher M, Hsu CY, Lin W.

Stroke. 2000 Apr;31(4):946-54.

20.

Diffusion-weighted magnetic resonance imaging during brief focal cerebral ischemia and early reperfusion: evolution of delayed infarction in rats.

Zarow GJ, Graham SH, Mintorovitch J, Chen J, Yang G, Weinstein PR.

Neurol Res. 1995 Dec;17(6):449-54.

PMID:
8622801
Items per page

Supplemental Content

Support Center